Skip to main content
Caplight Logo









XM Therapeutics

XM Therapeutics

Private
Providence, Rhode IslandHealthcare & Life Scienceshttps://www.xmtherapeutics.com/

Last Round

Seed

Oct 10, 2023

Total Funding Raised

$375,000

Company Overview

XM Therapeutics is a biotechnology company developing novel therapies based on injectable extracellular matrix particles to repair and modulate diseased tissue for treating chronic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

extracellular matrixECM particlestissue regenerationinjectable biologicsacellular therapyregenerative medicineECM technology platformfibrosis treatmentoff-the-shelf biologicsheart failure treatmentpulmonary fibrosischronic wound treatment3D cell culturebiotech platformuniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

XM Therapeutics Comparables

Compare XM Therapeutics with similar companies based on industry and business-model similarity.

XM Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ECM Therapeutics, Inc.
81%
Ventrix Bio
77%
TissueForm, Inc.
67%

XM Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 10, 2023

XM Therapeutics Investors

Notable investors and investment history

XM Therapeutics investors
InvestorRounds
Longevity Investor NetworkSeed
Slater Technology FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 10, 2023

    $375K round led by Slater Technology Fund

XM Therapeutics Filings

Explore SEC and related filing metadata, where available.

XM Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about XM Therapeutics's valuation, stock price, and market status.

Is XM Therapeutics a public or private company?

XM Therapeutics is a private company.

What is the current stock price of XM Therapeutics?

XM Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is XM Therapeutics worth (valuation)?

Valuation information for XM Therapeutics is not publicly available.

Can I buy XM Therapeutics stock?

XM Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was XM Therapeutics's last funding round?

Funding round information for XM Therapeutics is not publicly available.

Who are the main investors in XM Therapeutics?

Investor information for XM Therapeutics is not publicly disclosed.

Will XM Therapeutics IPO soon?

No public IPO plans have been announced for XM Therapeutics.

How can I track XM Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor XM Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersProvidence, Rhode Island
Year Founded2022
Last FundingOct 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?